Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling

Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signaling

US Patent 8603817 · Granted Dec 10, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mature cardiomyocyte compositions2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepati2025
Pyrazolopyridine compounds for the treatment of autoimmune disease2025
Tricyclic compounds for the treatment of cancer2025
Human alpha fetoprotein-specific t cell receptors and uses thereof2024
Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of 2024
Piperazine compounds for the treatment of autoimmune disease2024
Trans-indoline cyclopropylamine chemical compound, and method for preparation, p2024
Methods of treating or alleviating adenylosuccinatelyase (ADSL) deficiency using2023